Blood Pressure Measurement Device, Number and Timing of Visits, and Intra‐Individual Visit‐to‐Visit Variability of Blood Pressure
dc.contributor.author | Levitan, Emily B. | en_US |
dc.contributor.author | Kaciroti, Niko | en_US |
dc.contributor.author | Oparil, Suzanne | en_US |
dc.contributor.author | Julius, Stevo | en_US |
dc.contributor.author | Muntner, Paul | en_US |
dc.date.accessioned | 2012-12-11T17:37:16Z | |
dc.date.available | 2014-01-07T14:51:08Z | en_US |
dc.date.issued | 2012-11 | en_US |
dc.identifier.citation | Levitan, Emily B.; Kaciroti, Niko; Oparil, Suzanne; Julius, Stevo; Muntner, Paul (2012). "Blood Pressure Measurement Device, Number and Timing of Visits, and Intra‐Individual Visit‐to‐Visit Variability of Blood Pressure." The Journal of Clinical Hypertension 14(11). <http://hdl.handle.net/2027.42/94447> | en_US |
dc.identifier.issn | 1524-6175 | en_US |
dc.identifier.issn | 1751-7176 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/94447 | |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.publisher | Wiley Periodicals, Inc. | en_US |
dc.title | Blood Pressure Measurement Device, Number and Timing of Visits, and Intra‐Individual Visit‐to‐Visit Variability of Blood Pressure | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Oncology and Hematology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | the Department of Biostatistics, Center for Human Growth and Development, University of Michigan, Ann Arbor, MI; | en_US |
dc.contributor.affiliationum | the Department of Internal Medicine, University of Michigan, Ann Arbor, MI; | en_US |
dc.contributor.affiliationother | and the Department of Epidemiology, School of Public Health, University of Alabama, Birmingham, AL | en_US |
dc.contributor.affiliationother | From the Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL; | en_US |
dc.contributor.affiliationother | the Vascular Biology and Hypertension Program, Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL; | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/94447/1/jch.12005.pdf | |
dc.identifier.doi | 10.1111/jch.12005 | en_US |
dc.identifier.source | The Journal of Clinical Hypertension | en_US |
dc.identifier.citedreference | Fitzmaurice GM, Laird NM, Ware JH. Applied Longitudinal Analysis. Hoboken, NJ: Wiley; 2004. | en_US |
dc.identifier.citedreference | Muntner P, Shimbo D, Tonelli M, et al. The relationship between visit‐to‐visit variability in systolic blood pressure and all‐cause mortality in the general population: findings from NHANES III, 1988 to 1994. Hypertension. 2011; 57: 160 – 166. | en_US |
dc.identifier.citedreference | Rothwell PM, Howard SC, Dolan E, et al. Effects of β‐blockers and calcium‐channel blockers on within‐individual variability in blood pressure and risk of stroke. Lancet Neurol. 2010; 9: 469 – 480. | en_US |
dc.identifier.citedreference | Rothwell PM, Howard SC, Dolan E, et al. Prognostic significance of visit‐to‐visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010; 375: 895 – 905. | en_US |
dc.identifier.citedreference | Brickman AM, Reitz C, Luchsinger JA, et al. Long‐term blood pressure fluctuation and cerebrovascular disease in an elderly cohort. Arch Neurol. 2010; 67: 564 – 569. | en_US |
dc.identifier.citedreference | Zhimin J, Guoying S, Xiaowei Z, et al. Intensified antihypertensive therapy and blood pressure variability in older than 70 of Chinese hypertensive patients. Heart. 2011; 97: A193. | en_US |
dc.identifier.citedreference | Webb AJS, Fischer U, Mehta Z, Rothwell PM. Effects of antihypertensive‐drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta‐analysis. Lancet. 2010; 375: 906 – 915. | en_US |
dc.identifier.citedreference | Webb AJS, Fischer U, Rothwell PM. Effects of β‐blocker selectivity on blood pressure variability and stroke. Neurology. 2011; 77: 731 – 737. | en_US |
dc.identifier.citedreference | Julius S, Nesbitt SD, Egan BM, et al. Feasibility of treating prehypertension with an angiotensin‐receptor blocker. N Engl J Med. 2006; 354: 1685 – 1697. | en_US |
dc.identifier.citedreference | Julius S, Nesbitt S, Egan B, et al. Trial of preventing hypertension: design and 2‐year progress report. Hypertension. 2004; 44: 146 – 151. | en_US |
dc.identifier.citedreference | Muntner P, Joyce C, Levitan EB, et al. Reproducibility of visit‐to‐visit variability of blood pressure measured as part of routine clinical care. J Hypertens. 2011; 29: 2332 – 2338. | en_US |
dc.identifier.citedreference | Royston P, Altman DG. Regression using fractional polynomials of continuous covariates: parsimonious parametric modeling. Appl Statist. 1994; 43: 429 – 467. | en_US |
dc.identifier.citedreference | Mancia G, Facchetti R, Parati G, Zanchetti A. Visit‐to‐visit blood pressure variability in the European Lacidipine Study on Atheroscelerosis: methodological aspects and effects of antihypertensive treatment. J Hypertens. 2012; 30: 1241 – 1251. | en_US |
dc.identifier.citedreference | Gurland J, Tripathi RC. A simple approximation for unbiased estimation of the standard deviation. Am Stat. 1971; 25: 30 – 32. | en_US |
dc.identifier.citedreference | Jarrett RF. A minor exercise in history. Am Stat. 1968; 22: 25 – 26. | en_US |
dc.identifier.citedreference | Powers BJ, Olsen MK, Smith VA, et al. Measuring blood pressure for decision making and quality reporting: where and how many measures? Ann Intern Med. 2011; 154: 781 – 788. | en_US |
dc.identifier.citedreference | Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans and experimental animals. Hypertension. 2005; 45: 142 – 161. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.